Simplify Health Care ETF (PINK) Holdings
PINK holdings summary
as of Oct 25, 2026- Holdings
- 51 positions listed
- Top 10 weight
- 57.9% of net assets
- Effective holdings
- 22 equal-weight equivalent
- Largest holding
- ARQT 7.84% Arcutis Biotherapeutics, Inc.
- Annual turnover
- 117.3% of the portfolio traded
All PINK holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | ARQT | Arcutis Biotherapeutics, Inc. | Healthcare | 7.84% | $25.5M | $3.62B | 131.0 |
| 2 | JNJ | Johnson & Johnson | Healthcare | 7.46% | $24.3M | $615.87B | 38.8 |
| 3 | HUM | Humana Inc. | Healthcare | 7.25% | $23.6M | $49.61B | 39.1 |
| 4 | UTHR | United Therapeutics Corporation | Healthcare | 6.64% | $21.6M | $22.87B | 19.1 |
| 5 | ABBV | AbbVie Inc. | Healthcare | 5.21% | $17.0M | $504.37B | 80.6 |
| 6 | LLY | Eli Lilly and Company | Healthcare | 5.02% | $16.4M | $1.12T | 42.2 |
| 7 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 4.74% | $15.4M | $255.13B | 37.1 |
| 8 | UNH | UnitedHealth Group Incorporated | Healthcare | 4.73% | $15.4M | $360.32B | 25.8 |
| 9 | AVTR | Avantor, Inc. | Healthcare | 4.53% | $14.8M | $11.11B | — |
| 10 | WRBY | Warby Parker Inc. | Healthcare | 4.52% | $14.7M | $2.89B | 389.0 |
| 11 | GILD | Gilead Sciences, Inc. | Healthcare | 3.60% | $11.7M | $193.67B | — |
| 12 | DGX | Quest Diagnostics Incorporated | Healthcare | 3.38% | $11.0M | $25.94B | 24.6 |
| 13 | JAZZ | Jazz Pharmaceuticals plc | Healthcare | 3.06% | $10.0M | $13.65B | 14.4 |
| 14 | BNTC | Benitec Biopharma Inc. | Healthcare | 2.85% | $9.3M | $282.9M | — |
| 15 | PCT | PureCycle Technologies, Inc. | Industrials | 2.69% | $8.8M | $616.8M | — |
| 16 | AMGN | Amgen Inc. | Healthcare | 2.49% | $8.1M | $233.82B | 26.9 |
| 17 | SMMT | Summit Therapeutics Inc. | Healthcare | 2.24% | $7.3M | $11.67B | — |
| 18 | GH | Guardant Health, Inc. | Healthcare | 2.21% | $7.2M | $21.28B | — |
| 19 | BHVN | Biohaven Ltd. | Healthcare | 2.19% | $7.1M | $1.63B | — |
| 20 | CVS | CVS Health Corporation | Healthcare | 1.91% | $6.2M | $118.13B | 24.3 |
| 21 | CAH | Cardinal Health, Inc. | Healthcare | 1.87% | $6.1M | $58.83B | 35.1 |
| 22 | GRAL | GRAIL, Inc. | Healthcare | 1.52% | $5.0M | $5.26B | — |
| 23 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 1.49% | $4.8M | $126.66B | 28.9 |
| 24 | ESTA | Establishment Labs Holdings Inc. | Healthcare | 1.02% | $3.3M | $1.76B | — |
| 25 | GEHC | GE HealthCare Technologies Inc. | Healthcare | 0.98% | $3.2M | $31.42B | 16.0 |
| 26 | HSIC | Henry Schein, Inc. | Healthcare | 0.95% | $3.1M | $9.63B | 25.2 |
| 27 | ELV | Elevance Health Inc. | Healthcare | 0.92% | $3.0M | $92.88B | 19.0 |
| 28 | PCRX | Pacira BioSciences, Inc. | Healthcare | 0.84% | $2.7M | $1.45B | 103.8 |
| 29 | DHR | Danaher Corporation | Healthcare | 0.59% | $1.9M | $161.01B | 40.8 |
| 30 | EW | Edwards Lifesciences Corporation | Healthcare | 0.46% | $1.5M | $49.92B | 51.5 |
| 31 | INSM | Insmed Incorporated | Healthcare | 0.36% | $1.2M | $21.02B | — |
| 32 | TGTX | TG Therapeutics, Inc. | Healthcare | 0.32% | $1.0M | $8.26B | 19.6 |
| 33 | COO | The Cooper Companies, Inc. | Healthcare | 0.22% | $713,597.44 | $11.02B | 19.9 |
| 34 | AGL | agilon health, inc. | Healthcare | 0.21% | $688,193.24 | $1.43B | — |
| 35 | SYK | Stryker Corporation | Healthcare | 0.19% | $619,471.62 | $113.02B | 30.5 |
| 36 | FULC | Fulcrum Therapeutics, Inc. | Healthcare | 0.16% | $534,790.96 | $278.8M | — |
| 37 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 0.13% | $427,963.04 | $13.79B | 19.9 |
| 38 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | 0.12% | $403,210.24 | $18.12B | 23.1 |
| 39 | ABT | Abbott Laboratories | Healthcare | 0.10% | $325,043.47 | $181.50B | 33.8 |
| 40 | ICLR | ICON Public Limited Company | Healthcare | 0.08% | $252,739.21 | $13.13B | 179.1 |
| 41 | FLR | Fluor Corporation | Industrials | 0.07% | $240,037.11 | $6.28B | — |
| 42 | TFX | Teleflex Incorporated | Healthcare | 0.06% | $179,783.56 | $5.53B | — |
| 43 | SRPT | Sarepta Therapeutics, Inc. | Healthcare | 0.04% | $127,672.38 | $1.81B | — |
| 44 | PRAX | Praxis Precision Medicines, Inc. | Healthcare | 0.03% | $86,634.83 | $6.75B | — |
| 45 | VLTO | Veralto Corporation | Industrials | 0.02% | $74,584.12 | $24.63B | 25.8 |
| 46 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 0.02% | $61,556.33 | $81.41B | 19.6 |
| 47 | BMY | Bristol-Myers Squibb Company | Healthcare | 0.02% | $60,579.24 | $122.05B | 13.2 |
| 48 | AAVXF | ABIVAX Société Anonyme | Healthcare | 0.01% | $20,518.78 | — | — |
| 49 | EMBC | Embecta Corp. | Healthcare | 0.01% | $17,261.83 | $355.3M | 4.3 |
| 50 | NVO | Novo Nordisk A/S | Healthcare | 0.00% | $13,679.18 | $171.36B | 9.1 |
| 51 | SNDX | Syndax Pharmaceuticals, Inc. | Healthcare | 0.00% | $9,445.15 | $1.15B | — |
Weights as a percentage of net assets. Value held = weight × net assets ($325.7M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
PINK sector breakdown
| Sector | Weight | Holdings | Largest |
|---|---|---|---|
| Healthcare | 94.6% | 48 | ARQT, JNJ, HUM |
| Industrials | 2.8% | 3 | PCT, FLR, VLTO |
Sum of the weights of the holdings in each sector.
PINK top industries
PINK overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| DIA | SPDR Dow Jones Industrial Average ETF | 10.2% | 3 of 30 | 0.16% |
| SPY | SPDR S&P 500 ETF | 6.1% | 24 of 502 | 0.09% |
| VTI | Vanguard Total Stock Market ETF | 5.7% | 46 of 2,941 | 0.03% |
| QQQ | Invesco QQQ ETF | 2.6% | 5 of 101 | 0.17% |
| IWM | iShares Russell 2000 ETF | 1.0% | 16 of 1,962 | 0.19% |
| VXUS | Vanguard Total International Stock ETF | 0.0% | 3 of 8,035 | 0.05% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the PINK portfolio
Simplify Health Care ETF holds 51 positions. The ten largest make up 57.9% of the fund and the top 50 97.3%, so it behaves like a portfolio of about 22 equally weighted stocks. The biggest positions are Arcutis Biotherapeutics, Inc. (7.84%), Johnson & Johnson (7.46%), Humana Inc. (7.25%), United Therapeutics Corporation (6.64%), AbbVie Inc. (5.21%).
By sector, Healthcare is 94.6%, Industrials is 2.8%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: PINK chart, PINK performance, PINK dividends, PINK overview.
PINK holdings FAQ
How many holdings does PINK have?
PINK holds 51 positions as of October 25, 2026.
What are the top 10 holdings of PINK?
The ten largest holdings are Arcutis Biotherapeutics, Inc. (7.84%), Johnson & Johnson (7.46%), Humana Inc. (7.25%), United Therapeutics Corporation (6.64%), AbbVie Inc. (5.21%), Eli Lilly and Company (5.02%), Thermo Fisher Scientific Inc. (4.74%), UnitedHealth Group Incorporated (4.73%), Avantor, Inc. (4.53%), Warby Parker Inc. (4.52%). Together they are 57.9% of the fund.
What percentage of PINK is Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. is the largest holding at 7.84% of net assets, about $25.5M of the fund's $325.7M.
How concentrated is PINK?
The top 10 holdings are 57.9% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) PINK behaves like a portfolio of about 22 equally weighted stocks.